Professional practices in the management of adrenal insufficiency in two tertiary referral hospitals (Tunis, Tunisia)

Authors

  • Melika Chihaoui
  • Hanen Boukhadeja
  • Nadia Khessairi
  • Ibtissem Oueslati
  • Zohra Ben Amor
  • Fatma Chaker
  • Meriem Yazidi

Abstract

Background: Adrenal insufficiency (AI) is a rare and life-threatening disease. Glucocorticoid replacement therapy and patient education are crucial. Few is known about physician practice in this topic.
Aims: To describe physician practice in the management of AI and to identify the associated factors.
Methods: the physicians, all grades and specialties, from two university hospitals in Tunis, were invited to respond to a paper-based 16- multiple choice item-questionnaire about the management of AI and the prevention of acute AI. Each question was scored 1 if correct or 0 if incorrect. The global score was calculated by adding the score of the first 15 questions.
Results: 200 physicians responded to the questionnaire, sex ratio: 0.47, mean age: 29.0 ± 5.8 years (24 - 60). The overall rate of correct answers was 59.6%. The rate of correct responses was good for the type of replacement therapy (92%), the lifelong duration of treatment (88%), the symptoms of overtreatment (73.5%), the type of diet indicated (77%), and the necessity of special measures during the peri operative period (100%). However, the rate of correct responses was low for the half-life of hydrocortisone (12.5%), biological signs suggesting acute AI (17.5%), situations during which an increase in the dose of glucocorticoid is required (26.5%) and the risks of intermittent fasting (2%). Endocrinology specialty and overall medical specialties were independently associated with a better global score.
Conclusion: physician practice in the management of AI need to be improved.

Downloads

Download data is not yet available.

References

Bensing S, Hulting AL, Husebye ES, Kämpe O, Løvås K. Management of endocrine disease: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review. Eur J Endocrinol 2016 Sep;175(3):R107-16. doi: 10.1530/EJE-15-1242.

Chabre O, Goichot B, Zenaty D, Bertherat J. Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, longterm morbidity and mortality. Ann Endocrinol (Paris) 2017 Dec;78(6):490-494. doi: 10.1016/j.ando.2017.10.010.

Smans LC, Van der Valk ES, Hermus AR, Zelissen PM. Incidence of adrenal crisis in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2016 Jan;84(1):17-22. doi: 10.1111/cen.12865.

Hahner S. Acute adrenal crisis and mortality in adrenal insufficiency: Still a concern in 2018! Ann Endocrinol (Paris) 2018 Jun;79(3):164-166. doi: 10.1016/j.ando.2018.04.015.

Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet 2021 Feb 13;397(10274):613-629. doi: 10.1016/S0140-6736(21)00136-7.

Guignat L. Therapeutic patient education in adrenal insufficiency. Ann Endocrinol (Paris) 2018 Jun;79(3):167- 173. doi: 10.1016/j.ando.2018.03.002.

Bouziane T, Belmahi N, Salhi H, El Ouahabi H. Knowledge and attitude of patients with adrenal insufficiency. Ann Afr Med 2020 Oct-Dec;19(4):252-257. doi: 10.4103/aam.aam_63_19.

Van Eck JP, Gobbens RJ, Beukers J, Geilvoet W, Van Der Lely AJ, Neggers SJ. Much to be desired in self-management of patients with adrenal insufficiency. Int J Nurs Pract 2016 Feb;22(1):61-9. doi: 10.1111/ijn.12368.

Harsch IA, Schuller A, Hahn EG, Hensen J. Cortisone replacement therapy in endocrine disorders - quality of self-care. J Eval Clin Pract 2010 Jun;16(3):492-8. doi: 10.1111/j.1365-2753.2009.01149.x.

Harbeck B, Brede S, Witt C, Süfke S, Lehnert H, Haas C. Glucocorticoid replacement therapy in adrenal insufficiency- -a challenge to physicians? Endocr J. 2015;62(5):463-8. doi: 10.1507/endocrj.EJ14-0612.

Kampmeyer D, Lehnert H, Moenig H, Haas CS, Harbeck B. A strong need for improving the education of physicians on glucocorticoid replacement treatment in adrenal insufficiency: An interdisciplinary and multicentre evaluation. Eur J Intern Med 2016 Sep;33:e13-5. doi: 10.1016/j.ejim.2016.04.006.

Makin V, Nowacki AS, Colbert CY. A Pilot Assessment of Primary Care Providers’ Knowledge of Adrenal Insufficiency Diagnosis and Management. J Prim Care Community Health 2019;10:1-5. doi:10.1177/2150132719862163

Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, et al. Management of endocrine disease: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol 2017 Nov;177(5):R231-R248. doi: 10.1530/EJE-17-0154.

Camozzi V, Betterle C, Frigo AC, Zaccariotto V, Zaninotto M, De Caneva E, et al. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison’s disease on glucocorticoid and mineralocorticoid replacement therapy. Endocrine 2018 Feb;59(2):319-329. doi: 10.1007/s12020-017-1380-8.

Chihaoui M, Yazidi M, Chaker F, Belouidhnine M, Kanoun F, Lamine F, et al. Bone Mineral Density in Sheehan’s Syndrome; Prevalence of Low Bone Mass and Associated Factors. J Clin Densitom 2016 Oct;19(4):413-418. doi: 10.1016/j.jocd.2016.02.002.

Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol 2010 Mar;162(3):597-602. doi: 10.1530/EJE-09-0884.

Guignat L, Proust-Lemoine E, Reznik Y, Zenaty D. Group 6. Modalities and frequency of monitoring of patients with adrenal insufficiency. Patient education. Ann Endocrinol (Paris) 2017 Dec;78(6):544-558. doi: 10.1016/j. ando.2017.10.009.

Rushworth RL, Torpy DJ, Falhammar H. Adrenal crises: perspectives and research directions. Endocrine 2017 Feb;55(2):336-345. doi: 10.1007/s12020-016-1204-2.

Dineen R, Thompson CJ, Sherlock M. Adrenal crisis: prevention and management in adult patients. Ther Adv Endocrinol Metab 2019 Jun 13;10:2042018819848218. doi: 10.1177/2042018819848218.

Chihaoui M, Chaker F, Yazidi M, Grira W, Ben Amor Z, Rejeb O, et al. Ramadan fasting in patients with adrenal insufficiency. Endocrine. 2017 Jan;55(1):289-295. doi: 10.1007/s12020-016-1186-0.

Chihaoui M, Grira W, Bettaieb J, Yazidi M, Chaker F, Rejeb O, et al. The risk for hypoglycemia during Ramadan fasting in patients with adrenal insufficiency. Nutrition 2018 Jan;45:99- 103. doi: 10.1016/j.nut.2017.07.014.

Chihaoui M, Yazidi M, Oueslati I, Khessairi N, Chaker F. Intermittent fasting in adrenal insufficiency patients: a review and guidelines for practice. Endocrine 2021 Oct;74(1):11-19. doi: 10.1007/s12020-021-02804-z.

Downloads

Published

2022-03-09

Issue

Section

Original articles